News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,742 Results
Type
Article (26324)
Company Profile (60)
Press Release (367356)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104369)
Career Advice (455)
Deals (16886)
Drug Delivery (53)
Drug Development (47725)
Employer Resources (47)
FDA (12346)
Job Trends (8482)
News (186322)
Policy (19522)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1757)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26824)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12679)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3059)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42927)
Collaboration (849)
Compensation (271)
Complete response letters (16)
COVID-19 (1553)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4220)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3712)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38611)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54180)
Executive appointments (584)
FDA (14619)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (750)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (541)
Government (3142)
Grass and pollen (4)
Guidances (229)
Healthcare (12210)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1684)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7071)
IRA (23)
Job creations (1845)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3646)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13296)
Medtech (13341)
Mergers & acquisitions (10326)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1687)
NextGen: Class of 2026 (3933)
Non-profit (2835)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (349)
Peanut (42)
People (35633)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12335)
Phase 2 (18564)
Phase 3 (15261)
Pipeline (3023)
Policy (125)
Postmarket research (1668)
Preclinical (3797)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2869)
Recruiting (18)
Regulatory (15680)
Reports (18)
Research institute (1652)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2133)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (502)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Today (15)
Last 7 days (303)
Last 30 days (1227)
Last 365 days (16162)
2026 (1471)
2025 (16467)
2024 (19845)
2023 (22735)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18905)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25485)
Australia (4029)
California (5566)
Canada (1903)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49868)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3734)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1921)
New Mexico (10)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2643)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (523)
South Carolina (59)
Southern California (2234)
Tennessee (124)
Texas (1017)
United States (21591)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
393,742 Results for "xtant medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
Xtant Medical Holdings, Inc. announced the full commercial launch of two amniotic membrane allografts, SimpliGraft™ and SimpliMax™.
April 30, 2024
·
4 min read
Press Releases
Companion Spine LLC Announces Definitive Agreement to Acquire the Business and Assets of Paradigm Spine GmbH and the Coflex® and CoFix® Spine Implants from Xtant™ Medical Holdings, Inc.
July 8, 2025
·
13 min read
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical Holdings, Inc. today announced that management will participate in two upcoming investor conferences.
February 5, 2024
·
1 min read
Business
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical Holdings, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024.
May 8, 2024
·
1 min read
Business
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical Holdings, Inc. reported financial and operating results for the fourth quarter and year ended December 31, 2023.
April 1, 2024
·
13 min read
Press Releases
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025
March 3, 2025
·
1 min read
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Xtant Medical Holdings, Inc. today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.
May 22, 2024
·
1 min read
Business
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the first quarter ended March 31, 2024.
May 15, 2024
·
13 min read
BioForest
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical Holdings, Inc. announced that the Company’s revolving credit agreement with MidCap Financial Trust was amended to increase the commitment from $8.0 million to $17.0 million.
March 7, 2024
·
4 min read
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
Xtant Medical Holdings, Inc. (NYSE American: XTNT) today announced that Sean Browne, Chief Executive Officer, will present at the TD Cowen 44th Annual Healthcare Conference, to be held on Monday, March 4, 2024 at 12:50 p.m. Eastern Time in Boston.
February 26, 2024
·
1 min read
1 of 39,375
Next
